secwatch / observer
8-K filed February 14, 2024, 6:59 PM ET ticker EVH CIK 0001628908
leadership confidence high sentiment neutral materiality 0.40

Evolent appoints Headspace CEO Russell Glass to board; Sotunde retires

Evolent Health, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Russell Glass

Director
EVH · Evolent Health, Inc.
Effective
2024-02-14
Filed
February 14, 2024, 6:59 PM ET
On February 14, 2024, the Board appointed Mr. Russell Glass to the Board with a term expiring at the Company’s 2024 annual meeting of stockholders
Departed

Tunde Sotunde

Director
EVH · Evolent Health, Inc.
Effective
2024-02-12
Filed
February 14, 2024, 6:59 PM ET
On February 12, 2024, Dr. Tunde Sotunde retired from the Board of Directors (the “Board”) of Evolent Health, Inc., (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Russell Glass was appointed as Director at Evolent Health, Inc..

Action
appointed
Role
Director
Exact text from the filing
On February 14, 2024, the Board appointed Mr. Russell Glass to the Board with a term expiring at the Company’s 2024 annual meeting of stockholders
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Tunde Sotunde retired as Director at Evolent Health, Inc..

Action
retired
Role
Director
Exact text from the filing
On February 12, 2024, Dr. Tunde Sotunde retired from the Board of Directors (the “Board”) of Evolent Health, Inc., (the “Company”).
View on SEC.gov

Evolent Health, Inc. filing history →

Source: SEC EDGAR
accession 0001628908-24-000010
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.